We found previously that Lyn activity and protein levels are elevated significantly in human biopsies of GBM [17], consistent with the earlier report that 15% of GFAP-v-Src transgenic mice spontaneously develop low-grade gliomas that progress to GBM tumors [20]. This evidence concerns the gene LYN and central nervous system cancer.